Hepcinat Plus is a direct-acting antiviral combination drug for the treatment of hepatitis C, manufactured by Natco Pharma Ltd., an Indian pharmaceutical company. Medication is an ideal combination of two active ingredients. It includes Sofosbuvir and Daclatasvir and can be taken alone or as part of complex therapy.
